Viking Therapeutics Inc (VKTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $32.97
• Market Cap: $3.83B
• EPS: $-3.19
• 52-Week High: $43.15
• 52-Week Low: $18.92

Market Sentiment

Viking Therapeutics Inc currently has a Bullish sentiment score of 0.38.

About Viking Therapeutics Inc

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, specializing in the development of innovative therapies targeting metabolic and endocrine disorders. The company's robust pipeline includes novel drug candidates designed to address significant unmet medical needs, with a focus on conditions such as obesity and liver disease. Leveraging its proprietary drug development platforms and expertise in metabolic pathways, Viking aims to enhance pa...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Viking Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VKTX pay dividends?

Viking Therapeutics Inc (VKTX) does not currently pay a regular dividend.

What is VKTX's market cap?

Viking Therapeutics Inc (VKTX) has a market capitalization of $3.83B with a current stock price of $32.97.